Travere Therapeutics (TVTX) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free TVTX Stock Alerts $6.75 +0.20 (+3.05%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Travere Therapeutics Stock Price Performance5 Day Performance+9.58%1 Month Performance-4.12%3 Month Performance-18.48%6 Month Performance-5.99%Year-To-Date Performance-24.92%1 Year Performance-59.82% Receive TVTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest TVTX Stock Chart for Wednesday, May, 8, 2024 TVTX Chart by TradingView Travere Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$6.55$6.75+3.05%$7.69$6.741.94 million shs$513.74 million05/06/2024$6.26$6.55+4.63%$6.58$6.211.38 million shs$498.51 million05/03/2024$6.16$6.26+1.62%$6.56$6.18767,565 shs$476.45 million05/02/2024$6.00$6.16+2.67%$6.21$5.79823,572 shs$468.84 million05/01/2024$5.53$6.00+8.50%$6.11$5.541.88 million shs$456.65 million04/30/2024$5.46$5.53+1.28%$5.76$5.301.32 million shs$420.89 million Get the Latest News and Ratings for TVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$5.26$5.46+3.80%$5.57$5.241.58 million shs$415.56 million04/26/2024$5.39$5.26-2.41%$5.56$5.211.22 million shs$400.34 million04/25/2024$5.45$5.39-1.10%$5.50$5.121.48 million shs$410.23 million04/24/2024$5.74$5.45-5.05%$5.78$5.341.98 million shs$414.80 million04/23/2024$5.85$5.74-1.88%$5.96$5.711.24 million shs$436.87 million04/22/2024$5.72$5.85+2.27%$5.94$5.711.10 million shs$445.24 million04/19/2024$5.80$5.72-1.38%$5.91$5.58946,701 shs$435.35 million04/18/2024$5.99$5.80-3.17%$6.02$5.78972,249 shs$441.44 million04/17/2024$6.15$5.99-2.60%$6.34$5.941.31 million shs$455.89 million04/16/2024$6.32$6.15-2.69%$6.36$6.11747,661 shs$468.08 million04/15/2024$6.37$6.32-0.78%$6.49$6.201.55 million shs$481.02 million04/12/2024$6.69$6.37-4.78%$6.70$6.25937,230 shs$484.82 million04/11/2024$6.67$6.69+0.30%$6.85$6.521.90 million shs$509.18 million04/10/2024$6.86$6.67-2.77%$6.80$6.433.59 million shs$507.65 million04/09/2024$6.96$6.86-1.44%$7.26$6.82755,094 shs$522.12 million04/08/2024$7.04$6.96-1.14%$7.14$6.94534,602 shs$529.73 million04/05/2024$6.95$7.04+1.29%$7.13$6.65715,668 shs$535.81 million04/04/2024$6.98$6.95-0.43%$7.17$6.921.08 million shs$528.96 million04/03/2024$7.04$6.98-0.85%$7.15$6.871.25 million shs$531.25 million04/02/2024$7.31$7.04-3.69%$7.34$7.001.05 million shs$535.81 million04/01/2024$7.71$7.31-5.19%$7.77$7.251.07 million shs$556.36 million03/29/2024$7.71$7.71$7.98$7.41776,017 shs$586.73 million03/28/2024$7.67$7.71+0.52%$7.97$7.41776,017 shs$586.73 million03/27/2024$7.57$7.67+1.32%$8.06$7.111.10 million shs$583.69 million03/26/2024$7.69$7.57-1.56%$7.95$7.54988,583 shs$576.08 million03/25/2024$7.88$7.69-2.41%$8.12$7.69625,928 shs$585.21 million03/22/2024$8.09$7.88-2.60%$8.14$7.83952,352 shs$599.67 million03/21/2024$7.76$8.09+4.25%$8.41$7.721.03 million shs$615.65 million03/20/2024$7.48$7.76+3.74%$7.84$7.341.00 million shs$590.54 million03/19/2024$7.18$7.48+4.18%$7.52$7.111.33 million shs$569.23 million03/18/2024$7.49$7.18-4.14%$7.47$7.141.17 million shs$546.40 million03/15/2024$7.53$7.49-0.53%$7.81$7.462.33 million shs$569.99 million03/14/2024$8.15$7.53-7.61%$8.11$7.491.01 million shs$573.02 million03/13/2024$7.75$8.15+5.16%$8.39$7.711.18 million shs$620.20 millionThe Department of Defense Has a New Drone Contractor (Ad)The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest03/12/2024$7.99$7.75-3.00%$8.07$7.68978,074 shs$589.78 million03/11/2024$8.66$7.99-7.74%$8.72$7.971.12 million shs$608.04 million03/08/2024$8.71$8.66-0.57%$9.02$8.60651,169 shs$659.03 million03/07/2024$8.61$8.71+1.16%$8.94$8.58947,021 shs$662.83 million03/06/2024$8.04$8.61+7.09%$8.65$8.101.19 million shs$655.22 million03/05/2024$8.19$8.04-1.83%$8.16$7.801.42 million shs$611.84 million03/04/2024$7.87$8.19+4.07%$8.20$7.591.11 million shs$623.24 million03/01/2024$7.56$7.87+4.10%$8.01$7.581.33 million shs$598.91 million02/29/2024$7.79$7.56-2.95%$8.06$7.531.30 million shs$575.32 million02/28/2024$8.31$7.79-6.26%$8.27$7.781.27 million shs$592.82 million02/27/2024$8.02$8.31+3.62%$8.33$8.081.77 million shs$632.39 million02/26/2024$7.94$8.02+1.01%$8.13$7.81843,247 shs$610.32 million02/23/2024$7.86$7.94+1.02%$8.24$7.74999,403 shs$604.23 million02/22/2024$7.88$7.86-0.25%$8.05$7.661.30 million shs$590.68 million02/21/2024$8.28$7.88-4.83%$8.26$7.811.55 million shs$592.18 million02/20/2024$8.20$8.28+0.98%$8.28$7.981.44 million shs$622.24 million02/19/2024$8.20$8.20$8.99$8.061.28 million shs$616.23 million02/16/2024$8.74$8.20-6.18%$8.99$8.061.28 million shs$616.23 million02/15/2024$8.25$8.74+5.94%$8.82$8.291.46 million shs$656.78 million02/14/2024$7.99$8.25+3.25%$8.32$7.861.23 million shs$619.95 million02/13/2024$8.86$7.99-9.82%$8.57$7.801.36 million shs$600.45 million02/12/2024$8.48$8.86+4.48%$8.90$8.311.03 million shs$665.83 million02/09/2024$8.30$8.48+2.17%$8.64$8.28739,839 shs$637.27 million02/08/2024$8.28$8.30+0.24%$8.55$8.11834,067 shs$623.75 million02/07/2024$8.67$8.28-4.50%$8.65$8.27686,838 shs$622.24 million02/06/2024$8.26$8.67+4.96%$8.68$8.21730,687 shs$651.55 million Related Companies: Alto Neuroscience Stock Chart Annexon Stock Chart Acelyrin Stock Chart Theravance Biopharma Stock Chart Larimar Therapeutics Stock Chart Neurogene Stock Chart Fulcrum Therapeutics Stock Chart Entrada Therapeutics Stock Chart PepGen Stock Chart Corbus Pharmaceuticals Stock Chart Receive TVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TVTX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.